ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000251.1|Nogalamycin_1 # 2 # 1027 # -1 # ID=1_1;partial=10;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.693	BGC0000251.1|Nogalamycin_1 	2	1027	-	Loose	700	29.261	CMY-50	29.79	3002061	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGACCGTACACGTGTGGGACTATCTGCCGGAATACGAGCTGGAACGCGAGGACATCCACGATGCCGTGGAGACGGTGTTCCGCTCCGGCCGGCTCGTCCTCGGTGAGAGCGTGCGCGGCTTCGAGTCCGAGTTCGCCTCATTCCAGGGCGTCGGACATGCCGTCGGCGTCGACAACGGGACCAACGCCGTCAAGCTGGGGTTACAGGCCTTGGGTGTCGGGCCCGGCGACGAGGTCGTCACCGTGTCCAACACCGCCGCGCCCACGGTCGTCGCGATCGACTCGGCCGGTGCCACGCCCGTCTTCGTGGACGTGCGCGAGGAGGACTACCTGATGGACACGTCCCAGGTGGAGGCCGTCCTCACGCCACGCACCCGGTGTCTGCTGCCGGTCCACCTCTACGGGCAGTGCGTGGACATGGCACCGCTGCGCGATCTGGCCGCCCGGCACAACCTGGTGATCCTGGAGGACTGCGCGCAGGCGCACGGGGCGCGCCGGCACGGCCGACTCGCCGGCTCGACCGGTGACGCGGCCGCGTTCTCCTTCTACCCGACCAAGGTGCTGGGCGCGTACGGGGACGGCGGCGCGGTGCTCACCGACGACGAGCGGGTGGCGGACCGGCTGCGGCGGCTGCGCTACTACGGCATGGAGAGCCGCTACTACGTCGTCGAAACCCCCGGGCACAACAGCCGGCTGGACGAAGTACAGGCAGAGATCCTGCGGCGCAAGCTGTCCCGGTTGCCGTCCTACATCGAGGCCCGCCGGGCGGTGGCACGCCGCTATGAGGAGGGCCTGGCGGACACGGGGCTGCTGCTGCCGAGGACCGCGCAGGGCAACGAGCACGTCTACTACGTGTACGTGGTGCGCCATCCGCGACGGGACGCGGTGCTGGAGGCCCTGCGCGCCTCCTACGACATCGCCCTCAACATCAGTTATCCCTGGCCCGTGCACACCATGACCGGTTTCTCCCATCTCGGCTACGCCAAGGGCTCGTTGCCGGTCACCGAGGCACTGGCGGACGAGATC	MTVHVWDYLPEYELEREDIHDAVETVFRSGRLVLGESVRGFESEFASFQGVGHAVGVDNGTNAVKLGLQALGVGPGDEVVTVSNTAAPTVVAIDSAGATPVFVDVREEDYLMDTSQVEAVLTPRTRCLLPVHLYGQCVDMAPLRDLAARHNLVILEDCAQAHGARRHGRLAGSTGDAAAFSFYPTKVLGAYGDGGAVLTDDERVADRLRRLRYYGMESRYYVVETPGHNSRLDEVQAEILRRKLSRLPSYIEARRAVARRYEEGLADTGLLLPRTAQGNEHVYYVYVVRHPRRDAVLEALRASYDIALNISYPWPVHTMTGFSHLGYAKGSLPVTEALADEI	MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLATYTAGGLPLQIPDEVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGALAVQPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWCIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ	89.76	gnl|BL_ORD_ID|838|hsp_num:0	911			384	654	
BGC0000251.1|Nogalamycin_2 # 1192 # 2073 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.660	BGC0000251.1|Nogalamycin_2 	1192	2073	+	Loose	700	31.9574	CMY-160	21.68	3005183	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	GTGAAGGGAATCATTCTCGCCGGGGGTACGGGGAGCAGGCTCCACCCGACGACTCTCGCGGTGTCCAAGCAGCTTCTCCCCGTCGGGGACAAGCCGATGATCTACTACCCGCTCTCCGTGCTGATGCTGGCCGGCGTCACGGACATCCTCATCATCAGCACACCGCACGAACTCCCCCGAATGCGCCGTCTGTTCGGCGACGGCGCACAGCTCGGACTCCGCCTGGCCTACGCCGAGCAGGAGAAACCCAGGGGTATCGCCGAGGCGTTCCTGATCGGTGCCGACCACGTGGGAAGCGATGCCGTTGCGCTGGCGCTGGGCGACAACATATTCCACGGGAGTTCTTTTCAGGGGGTGCTGCGCAAGGAAGCCGAGGAATTGGACGGGTGTGTCCTGTTCGGTTATCCGGTCAAGGATCCCCAGCGTTATGGAGTCGGCGAGGCGAACGCGTCCGGGCGGCTCGTCTCCATCGAGGAGAAACCGGTACGCCCCCGCTCCAACCGGGCCATCACCGGACTCTATTTCTACGACAACGAGGTGGTGGACATCGCCCGGCGGCTGCGCCCCTCCGCCCGCGGCGAACTCGAAATCACCGACATCAACCGTACCTACATGGAACGAGGCCGGGCCCGGCTCGTGGACCTGGGCCGGGGATTCGCCTGGCTCGACACCGGCACACCCGAGTCACTCCTGCAGGCCTCGCAGTACGTGTCCGCCCTGGAGGAACGCCAGGGCATCAGGATCGCCTGCATCGAGGAGGTGGCCCTCCGCATGGGCTTCATCAACGCCCAGGCCTGCTACGAACTGGGCGCGCGCCTGTCCGGCTCCGGCTACGGGCAGTACGTGATGGCCATCGCGGAGGAGTGCACGGGGCGGGTGTGA	MKGIILAGGTGSRLHPTTLAVSKQLLPVGDKPMIYYPLSVLMLAGVTDILIISTPHELPRMRRLFGDGAQLGLRLAYAEQEKPRGIAEAFLIGADHVGSDAVALALGDNIFHGSSFQGVLRKEAEELDGCVLFGYPVKDPQRYGVGEANASGRLVSIEEKPVRPRSNRAITGLYFYDNEVVDIARRLRPSARGELEITDINRTYMERGRARLVDLGRGFAWLDTGTPESLLQASQYVSALEERQGIRIACIEEVALRMGFINAQACYELGARLSGSGYGQYVMAIAEECTGRV	MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHSSPGQLDAGAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ	76.90	gnl|BL_ORD_ID|2880|hsp_num:0	3899			672	1071	
BGC0000251.1|Nogalamycin_3 # 2106 # 2822 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.727	BGC0000251.1|Nogalamycin_3 	2106	2822	-	Loose	600	28.1054	Streptomyces venezuelae rox	28.57	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGTACGGCCGGGAACTGGCGGACGTGTACGAGATGGTCTACCGCAGCCGGGGAAAGAGCTGGGCGGACGAGGCCGAACGGGTCACCGCGGAGATCAGGTCCCGTCGGCCCGGGGCGCGTTCGCTGCTCGACGTCGCCTGCGGCACCGGCGCCCATCTGGAGGCCTTCCGCGGGCTGTTCGCGCACACGGAGGGCCTGGAGCTGTCGGACGAGATGCGGGCCCTGGCCGAACGGCGGCTGCCGGGGGTGCCGGTGCGGCCCGGGGACATGCGCGACTTCGCCCTGAGCGGGCGTTTCGACGCCGTGGTCTGCCTGTTCTGCTCCATCGGGTATCTGGAGACCGTCGCGGACATGCGGGCGGCGGTGCGCACGATGGCCGCGCACCTGGTGCCGGGCGGCGTGCTCGTGGTGGAGCCCTGGTGGTTCCCCGAGCGGTTCCTGGAGGGCTACGTCGCCGGGGACCTGGCACGCGGTGAGGGCCGGACCGTGGCCCGGGTGTCCCACTCCACCAGGCAGGGCCGCAGGACCCGCATGGAGGTGCGGTTCCTGGTCGGCGAGGCCACCGGGATACGCGAGTTCACGGAGATCGACCTGCTCACCCTGTTCACCAGGGAGGAGTACCTCGCCGCGTTCGAGGACGCGGGCTGCCCGGCCGAGTTCCTGGACGACGGGCTGACCGGCCGGGGGTTGTTCGTCGGGGTGCGCGGGGCCGGGTAA	MYGRELADVYEMVYRSRGKSWADEAERVTAEIRSRRPGARSLLDVACGTGAHLEAFRGLFAHTEGLELSDEMRALAERRLPGVPVRPGDMRDFALSGRFDAVVCLFCSIGYLETVADMRAAVRTMAAHLVPGGVLVVEPWWFPERFLEGYVAGDLARGEGRTVARVSHSTRQGRRTRMEVRFLVGEATGIREFTEIDLLTLFTREEYLAAFEDAGCPAEFLDDGLTGRGLFVGVRGAG	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	50.00	gnl|BL_ORD_ID|4833|hsp_num:0	5820			702	954	rifampin; rifaximin; rifapentine
BGC0000251.1|Nogalamycin_4 # 2826 # 3608 # -1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.710	BGC0000251.1|Nogalamycin_4 	2826	3608	-	Loose	420	26.9498	smeR	33.33	3003066	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCGGCTCATCGACCTTTCGTCACCGGTGGATTCCTCACAGTACGAGCCCGACCCGGTGGTGCACGACGTCCTCACGCCCCGGCAGGGCGCGGAACACATGTGCGCGGAGATGCGCGAGCACTTCGGTGTCGAGTTCTCTCCGGACGAACTGCCGGACGGCGAGTTCCTGTCACTGGACAGGATCACGCTGACCACGCACACCGGCACGCACGTCGACGCGCCGTCGCACTATGGTTCGCGCGCGCTGTACGGGGACGGCGTCCCCCGCCACATCGACCAGATGCCGCTGGAGTGGTTCTTCGGGCGCGGGGTGGTGCTGGACCTCACCGACGCTCCGACGGGCACCGTGAGCGCCGCGCGCCTGGAGAAGGAACTGGCCCGGACCGGGTGCGCGTTGCGGCCCGGGGACATCGTGCTGCTGCACACCGGTGCCCAGCGGCACGCGGGCACCCCGCGCTACTTCACGGACTTCGCCGGTCTCGACGGGCCCGCGGTACGGATGCTTCTCGACCACGGGGTCCGGGTGATCGGGACCGATGCCTTCAGCCTGGACGCGCCCTTCGGCCACATCATCGACCGGTACCGCGCGACCGGCGACCGATCGGTGCTGTGGCCCGCGCACGTGGTGGGCCGGGAGCGGGAGTACTGCCAGATCGAGCGGCTGGCGAACCTCGACCGCCTGCCGGTCTCCTTCGGGTTCCGCGTCTGCTGCTTCCCGGTCAAGGTCGCCGGCGCCGGCGCCGGGTGGACCCGGGCGGTCGCCCTGGTGGACGAGGACTGA	MRLIDLSSPVDSSQYEPDPVVHDVLTPRQGAEHMCAEMREHFGVEFSPDELPDGEFLSLDRITLTTHTGTHVDAPSHYGSRALYGDGVPRHIDQMPLEWFFGRGVVLDLTDAPTGTVSAARLEKELARTGCALRPGDIVLLHTGAQRHAGTPRYFTDFAGLDGPAVRMLLDHGVRVIGTDAFSLDAPFGHIIDRYRATGDRSVLWPAHVVGREREYCQIERLANLDRLPVSFGFRVCCFPVKVAGAGAGWTRAVALVDED	MSTSPATSTKILIVEDEPRLASVLRDYLAAAGMASEWVDDGGQVIDAFARYQPDLVLLDLMLPQRDGVDLCRELRASSDVPVIMVTARVEEIDRLLGLEIGADDYICKPFSPREVVARVMAVLRRYRPDPGARANGGLHIDEPAARATWNGKGLDLTPVEYRLLRTLLATPGRIWARDELLDRLYLDHRVVVDRTVDSHVRNLRRKLADAGMEGEPIRSVYGMGYSYEP	113.54	gnl|BL_ORD_ID|1425|hsp_num:0	1550			144	225	
BGC0000251.1|Nogalamycin_6 # 5088 # 6356 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.680	BGC0000251.1|Nogalamycin_6 	5088	6356	+	Loose	450	28.1054	ermZ	31.03	3004605	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGACAACCGCGAGACCGTACGACCGGTGAGCGTCTGCCGGGTCTGCGGCGGCAACGACTGGCAGGACGTCGTGGACTTCGGTGACGTTCCCCTCGCCAACGGCTTCCTGTCCCCGGCCGACTCCTACGAGAACGAGCGCCGCTACCCGCTGGGCGTCCTGTCCTGCCGCGCCTGCCGGCTGATGAGCCTGACCCACGTGGTCGACCCCGAGGTGCTGTACCGCGACTACGCCTACACCACCCCCGACTCCGAAATGATCACCCAGCACATGCGGCACATCACCGCGCTGTGCCGCACCCGTTTCGAGCTTCCCCCGGACAGCCTCGTCGTGGAGCTGGGCAGCAATACCGGCCGTCAGCTCATGGCCTTCCGCGAAGCGGGGATGCGCACCCTGGGCGTGGACCCCGCGCGCAACCTCACGGACGTCGCCCGGCGCAACGGCATCGAGACCTTCCCCGACTTCTTCTCCCACGACGTGGCCCGCACCATCCGGCGCGACCACGGGCAGGCGCGGCTCGTGCTGGGACGGCATGTCTTCGCCCACATCGACGACGTGTCGGACATCGCGGCCGGCGTACGCGAACTCCTGTCTCCCGACGGGGTGTTCGCGATCGAGGTGCCGTACGTTCTGGACCTGCTGGAGAAGGTCGCGTTCGACACCATCTACCACGAGCACTTGTCGTACTTCACCATGCGGTCCTTCGTCACCCTCTTCGCGCGCCACGGGCTGCGGGTGCTCGACGTGGAGCGGTTCGGCGTGCACGGCGGATCGGTCCTCGTCTTCGTGGGCCACGAGGACGGCCCCTGGCCCGAACGTCCCTCCGTCCCCGAACTGCTGCGCGTGGAACGGCAGCGGGGCCTCTACGACGACGCCACCTACCGCACGTTCGCGCAGCGGATCGAGCGGGTGCGCACCGAACTGCCGGAACTGCTGCGCTCCCTCGTGGCCCAGGGCAAGCGCATCGTCGGCTACGGTGCTCCGGCCAAGGGCAACACCATCCTCACGGTGTGCGGGCTCGGCCTGAAGGAGCTGGAATACTGCACCGACACCACCGAGCTGAAGCAGGGCAGGGTGCTGCCCGGCACCCACATACCGGTGCACGCTCCCGAGCACGCCAAGGAACACATCCCCGACTACTACCTGTTGCTCGCCTGGAACTACGCCACGGAGATCCTCGACAAGGAGACGGCCTTCCGGGACAACGGCGGCCGGTTCATCGTGCCCATCCCCCGCCCGTCGATCCTCACGTCCCCGTCAGGTTCCTGA	MDNRETVRPVSVCRVCGGNDWQDVVDFGDVPLANGFLSPADSYENERRYPLGVLSCRACRLMSLTHVVDPEVLYRDYAYTTPDSEMITQHMRHITALCRTRFELPPDSLVVELGSNTGRQLMAFREAGMRTLGVDPARNLTDVARRNGIETFPDFFSHDVARTIRRDHGQARLVLGRHVFAHIDDVSDIAAGVRELLSPDGVFAIEVPYVLDLLEKVAFDTIYHEHLSYFTMRSFVTLFARHGLRVLDVERFGVHGGSVLVFVGHEDGPWPERPSVPELLRVERQRGLYDDATYRTFAQRIERVRTELPELLRSLVAQGKRIVGYGAPAKGNTILTVCGLGLKELEYCTDTTELKQGRVLPGTHIPVHAPEHAKEHIPDYYLLLAWNYATEILDKETAFRDNGGRFIVPIPRPSILTSPSGS	MTLKSPLPPQSVSAPADSRSTARREWGQNFFRTAAAACRFSAQLDGSDTIPPDSPNDLMTVEIGAGSGRVTKVLASPGTPLLAVEIDPRWARRLAAESLPDVTVVNEDFLTLQLPGQPVRLIGNLPFVTGTRMLRRCLDMGPARMRQGVFLLQREYVGKRTGAWGGNLFNAQWEPWYSFDRGLAFSRQDFTPVPRADTQTLMVAPHRRPSVPWREKAAYQRFVQRVFDTGQMTVGDAARKVLRRGHAQFVRGAGVRPADRVKDLTVPEWTALFRAYGRTADR	149.65	gnl|BL_ORD_ID|225|hsp_num:0	3303			57	303	spiramycin
BGC0000251.1|Nogalamycin_7 # 6334 # 7209 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.771	BGC0000251.1|Nogalamycin_7 	6334	7209	-	Loose	1020	26.5646	vgaE	32.26	3002833	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	vga-type ABC-F protein	ATGCTCGCCCGGCACCTGACCGCGGCCCTGGCGGAGACCGGCAGGAGCCGGCCCGCCGCCGAGGCGGTGGTACTCGGGCGGCGCGCGCTGGACATCACCGACGGGCGGGCGGTGGACGCCGCGTTCGCCGCGCACCGGCCGCGGGTGGTGGTCAACTGCGCCGCCTTCACGGACGTGGACGGCGCCGAGTCGCGGTGGGCGGAGGCGATGCGCGTCAACGGCGGCGGGCCCCGGCTGCTGGCCCGCCGCTGTGCGCGCCACGGCGTACGGCTGATCCACGTCTCGACCGACTACGTCTTCCCGGGCGACACCCGCAGCCCTTACGGCGAGTCGGACGCTCCGGGCCCGCGCACGGTGTACGGCCGCAGCAAACTGGCCGGGGAACGGGCCGTGCTGTCGCTGCTGCCGGATACGGGCACCGTGGTGCGCACGGCGTGGCTCTACGGCGGGCAGGGCCGCAGCTTCGTGCGCACGATGCTGGAGCGTGCCCCGGACGACGGCCATGTCGACGTCGTCAACGACCAGTGGGGGCAGCCGACGTGGGCCGGTGACGTGGCCCGGCTGCTGGTGACGCTGGCCCGCACGCCGCCAGACCGGGCGCGCGGGATCTTCCACGCCACCAACGCCGGGGCGGCCACCTGGTACGAGCTGGCCCGGGAGGTGTTCCGGCTGGCGGGCGCGGACCCGGAACGGGTGCGCCCGGTGGCGACGGCCGACCGGCCGGGCCCGGCGCCCCGGCCGGCGTGCACGGTGCTCGGGCACGACCGCTGGCGGCTGGTCGGCGTCGCACCGCCCCGCGACTGGCGTGCAGCCCTGCGCGAGGCGATGCGTCAGCTGCTGCCCGGCGGGCGCCTCAGGAACCTGACGGGGACGTGA	MLARHLTAALAETGRSRPAAEAVVLGRRALDITDGRAVDAAFAAHRPRVVVNCAAFTDVDGAESRWAEAMRVNGGGPRLLARRCARHGVRLIHVSTDYVFPGDTRSPYGESDAPGPRTVYGRSKLAGERAVLSLLPDTGTVVRTAWLYGGQGRSFVRTMLERAPDDGHVDVVNDQWGQPTWAGDVARLLVTLARTPPDRARGIFHATNAGAATWYELAREVFRLAGADPERVRPVATADRPGPAPRPACTVLGHDRWRLVGVAPPRDWRAALREAMRQLLPGGRLRNLTGT	MLLFEGTSLKKHIQDRLLFDIDLIQVHEHQRIGLVGRNGTGKTSLLKIITGEELVDGGNVNHFTSVKLVPQFKETRSEKSGGEITQQYLQLAFNEKPGLLILDEPTTHLDTQRIDWLEKKLANYQGAFVVVSHDRTFLNNVCTEIWEIEDGSLNAFKGDYNAYAEQKELIKTQQQIAFEKYEREKKQLEKAIRQKEERAQRATKKPKNLSSSEARITGAKTHYANIQKKLRGSAKALETRLEQLDRIDKVKELPEIKMDILNKESLTNQSVLRAENIKGEVDGRKLWNPFSLYLYGGDKVAIIGKNGTGKTTLLKKIVERDERIAIPEKVRIGYFSQHLTILDDDKTIIENIQLTSSQDETLIRTVLARMHFWDEDVYKKVGILSGGEKVKVALAKLFLSDVNMLVLDEPTNFLDIESLEALETLMKSYHGTILFVTHDRTLVTNIATKIIDIKDGKITVFDGSYEAYEEWLENQTKSNNDDQLLLIETKISDVLGRLSLEPSRELEDEFQRLLKEKKELTKKL	55.53	gnl|BL_ORD_ID|1490|hsp_num:0	1626			1014	1107	clindamycin; virginiamycin M1; tiamulin
BGC0000251.1|Nogalamycin_8 # 7245 # 8297 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.710	BGC0000251.1|Nogalamycin_8 	7245	8297	-	Loose	1200	30.8018	arnA	21.1	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGGCGTCGCACACCTCCGCGACGACGGACGTGAACATCCTGGTCACCGGCGCGGTCGGTTTCATCGGCTCGGCCTATGTGCGCATGCTGCTGGAGAACCGGGCCCCCGGAGCGGGGGCCCCGGCGGTACGCGTCACCGTCCTCGACAAACTGACGTACGCGGGCAACCTCACGAACCTGGACGCGGTACGCGGTGACCGGCTGCGCTTCGTGCGGGGCGACATCCTCGACGCCGAGCTGGTCGACGAGCTGATGGCACACAGCGACCAGGTCGTCCACTTCGCCGCGGAGTCGCACGTCGACCGGTCCATCCGCGCGGCCGACGACTTCGTGCTGACCAACGTCGTCGGCACCCAGCGGCTGCTGGACGCCGCGCTGCGCCACGGCGTGGAGCCCTTCGTCCTGGTGTCCACGGACGAGGTCTACGGCTCCATCGCGTCCGGTTCCTGGCCGGAGGAGCACCCGCTGAGCCCCAACTCCCCGTACGCCGCCTCCAAGGCGTCGGCCGACCTGATGGCGTTCGCCTGCCACCGCACGCACGGCCTGGACGTGCGGGTGACCCGCTGTTCCAACAACTACGGCCCGCGTCAGCACCCGGAGAAGCTCATCCCGCGCTTCGTCACCAACTTGTTGGACGGGCTGCCGGTGCCGCTGTACGGGGACGGGCGGAACGTGCGGGAGTGGCTGCACGTGGAGGACCACTGCCGGGGCGTGGACCTGGTGCGCACCGCGGGCCGGCCCGGCGGTGTGTACCACATCGGCGGCGGCCGGGAGCTCTCCAACCGGGAGCTGGTGGGTATGTTGCTGGAGCTGTGCGGGGCGGACTGGAGCAGCGTCCGGCACGTGCCCGACCGCAAGGGGCACGACCTGCGTTACAGCCTGGACTGGGGCAGGGCCCGTGAGGAACTGGGCTACCGTCCGGCGCGGGAGTTCTCCTCGGGGCTGCGCTCGACGGTCCAGTGGTACCGCGAGAACCGGTCCTGGTGGGAGCCGCTCAAGCGGGGAGTCACGGCGCCGGGCGGTACGTCCACCGTCGTCCCCGGGGTCCGGTGA	MASHTSATTDVNILVTGAVGFIGSAYVRMLLENRAPGAGAPAVRVTVLDKLTYAGNLTNLDAVRGDRLRFVRGDILDAELVDELMAHSDQVVHFAAESHVDRSIRAADDFVLTNVVGTQRLLDAALRHGVEPFVLVSTDEVYGSIASGSWPEEHPLSPNSPYAASKASADLMAFACHRTHGLDVRVTRCSNNYGPRQHPEKLIPRFVTNLLDGLPVPLYGDGRNVREWLHVEDHCRGVDLVRTAGRPGGVYHIGGGRELSNRELVGMLLELCGADWSSVRHVPDRKGHDLRYSLDWGRAREELGYRPAREFSSGLRSTVQWYRENRSWWEPLKRGVTAPGGTSTVVPGVR	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	52.87	gnl|BL_ORD_ID|1513|hsp_num:0	1643			957	1629	polymyxin B
BGC0000251.1|Nogalamycin_9 # 8507 # 8941 # 1 # ID=1_9;partial=00;start_type=TTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.690	BGC0000251.1|Nogalamycin_9 	8507	8941	+	Loose	500	27.335	GIL-1	23.46	3006888	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	GIL beta-lactamase	TTGAGCCGTCAGACAGAGATCGTCCGCCGGATGGTGAGCGCCTTCAACACCGGCAGGACCGACGACGTGGACGAGTACATCCACCCCGACTACCTCAATCCGGCCACCTTGGAACACGGCATCCACACCGGGCCCAAGGCGTTCGCCCAGCTGGTCGGCTGGGTGCGGGCGACGTTCTCCGAGGAAGCCCGCCTGGAGGAGGTGCGGATCGAGGAGCGCGGCCCGTGGGTCAAGGCCTACCTCGTGCTCTACGGCCGCCACGTCGGCCGGCTTGTCGGTATGCCGCCCACCGACCGGCGCTTCTCCGGTGAACAGGTGCACCTGATGCGCATCGTCGACGGGAAGATCCGCGACCACCGGGACTGGCCCGACTTCCAGGGGACGCTGCGCCAGCTCGGCGACCCGTGGCCCGACGACGAGGGCTGGCGTCCGTGA	MSRQTEIVRRMVSAFNTGRTDDVDEYIHPDYLNPATLEHGIHTGPKAFAQLVGWVRATFSEEARLEEVRIEERGPWVKAYLVLYGRHVGRLVGMPPTDRRFSGEQVHLMRIVDGKIRDHRDWPDFQGTLRQLGDPWPDDEGWRP	MPHFRLALIPLLTAFCLPAFAHPTTLNKVKEAESQLTARVGYAELDLTSGEILESYRLQERFPMMSTFKVLLCGAVLARVDAGKERLDRRIPFSRRDLVEYSPVTEKHLTDGMTVGELCDAAITMSDNTAANLLLTAIGGPQGLTAFLRTTGDRVTRLDRWEPELNEALPGDKRDTTTPENMAQTLRQLLTGKILTTTSQQQLTHWMVTDKVAGPLLRSVLPAGWFIADKTGAGARGSRGIVAALGPDGKPSRIVVIYITESQATMAERNRQIAGIGATLIQHWDE	50.35	gnl|BL_ORD_ID|3561|hsp_num:0	4630			33	273	
BGC0000251.1|Nogalamycin_10 # 8992 # 9699 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.698	BGC0000251.1|Nogalamycin_10 	8992	9699	+	Loose	100	24.6386	FosI	33.96	3007370	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGCCGGATCCCGGCGGCCCGACCACGGCCGAGAACCTGTCGAAGGAGGCTGTCCGCTTCTACCGCGAGCAGGGTTACGTGCACATCCCGCGCGTCCTGTCGGAGACGGAGGTGACCGCCTTCCGGGCCGCCTGTGAGGAGGTCCTGGAGAAGGAGGGCCGCGAGATCTCCGGCATCGCCCTGCGGCTGGCCGGCGCGCCCCTGCGGGTCTACAGCAGCGACATCCTGGTCAAGGAGCCCAAGCGCACCCTGCCCACCCTGGTCCACGACGACGAGACGGGACTGCCGCTGAACGAGCTGAGTGCCACGCTGACGGCCTGGATCGCGCTGACGGACGTACCCGTCGAACGCGGCTGCATGAGCTACGTGCCGGGCTCCCATCTCAGGGCCCGCGAGGACCGGCAGGAGCACATGACCAGCTTCGCCGAGTTCCGGGACCTCGCGGACGTGTGGCCCGATTACCCGTGGCAGCCGCGCGTCGCCGTGCCCGTCCGCGCCGGAGACGTCGTGTTCCACCATTGCCGTACCGTCCACATGGCCGAAGCCAACACCAGCGACTCGGTCCGCATGGCGCATGGCGTCGTCTACATGGACGCGGACGCCACCTACCGGCCGGGCGTCCAGGACGGCCACCTGTCCCGCCTGTCGCCGGGAGATCCACTCGAAGGCGAGCTGTTCCCCCTGGTCACGGCAGGCACACGGCAGTGA	MPDPGGPTTAENLSKEAVRFYREQGYVHIPRVLSETEVTAFRAACEEVLEKEGREISGIALRLAGAPLRVYSSDILVKEPKRTLPTLVHDDETGLPLNELSATLTAWIALTDVPVERGCMSYVPGSHLRAREDRQEHMTSFAEFRDLADVWPDYPWQPRVAVPVRAGDVVFHHCRTVHMAEANTSDSVRMAHGVVYMDADATYRPGVQDGHLSRLSPGDPLEGELFPLVTAGTRQ	MKGISHITFIVRDLNRMAALLCEGLGAREVYDSSNQNFSLSREKFFVLGSTWLAAMEGEPPAERSYQHVAFAVSETDLPAYQARLEALGVEIRPPRSRVDGEGLSLYFYDFDNHLFELHSGTLEQRLVRYQAGR	175.37	gnl|BL_ORD_ID|4905|hsp_num:0	5898			186	333	fosfomycin
BGC0000251.1|Nogalamycin_11 # 9745 # 10881 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=3-4bp;gc_cont=0.734	BGC0000251.1|Nogalamycin_11 	9745	10881	-	Loose	700	81.2629	oleI	25.94	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGTGCGTTGTTCATCACTTCACCCGGGCTCAGCCACATCCTGCCGACGGTGCCGCTGGCACAGGCGCTGCGCGCTCTCGGCCACGAGGTCCGCTACGCCACGGGGGGCGACATCCGCGCCGTCGCGGAGGCCGGGCTGTGCGCCGTGGACGTGTCGCCCGGCGTGAACTACGCGAAGCTGTTCGTGCCCGACGACACCGACGTCACCGACCCGATGCACTCCGAGGGGCTGGGCGAGGGCTTCTTCGCCGAGATGTTCGCCCGGGTATCGGCGGTGGCCGTCGACGGGGCGCTGCGGACGGCGCGGAGCTGGCGGCCCGACCTCGTCGTGCACACTCCGACACAGGGCGCGGGCCCGCTGACGGCGGCAGCGCTGCAACTGCCGTGCGTAGAGCTGCCGCTGGGTCCCGCGGACAGCGAGCCGGGGCTCGGCGCGCTCATCCGGCGGGCGATGTCCAAGGACTACGAGCGCCACGGCGTCACCGGCGAGCCGACCGGTTCCGTGCGGCTGACGACGACACCGCCGAGCGTGGAGGCGCTGCTGCCGGAGGACCGGCGCTCCCCGGGTGCCTGGCCGATGCGGTACGTCCCCTACAACGGCGGAGCGGTGCTGCCGGACTGGCTGCCGCCCGCGGCCGGCCGGCGGCGTATCGCGGTGACGCTGGGCTCCATCGACGCGCTGTCGGGCGGCATCGCCAAGCTGGCCCCGCTGTTCTCCGAAGTGGCGGACGTGGACGCGGAGTTCGTGCTGACCCTGGGCGGCGGCGACCTGGCCCTGCTCGGTGAACTGCCCGCGAACGTACCGGTGGTGGAGTGGATTCCGCTGGGCGCGCTGCTGGAGACGTGCGACGCGATCATCCATCACGGGGGCAGCGGCACACTGCTGACGGCCCTGGCCGCCGGCGTCCCGCAGTGCGTCATCCCGCACGGCTCCTACCAGGACACCAACCGCGATGTGCTGACCGGGCTGGGCATCGGGTTCGATGCCGAGGCGGGATCGCTGGGTGCCGAGCAGTGCCGACGGCTGCTGGACGACGCGGGGTTGCGGGAGGCGGCCCTGCGGGTGCGGCAGGAGATGAGCGAGATGCCGCCGCCGGCCGAGACGGCCGCCAAGCTCGTGGCGCTGGCCGGCTGA	MRALFITSPGLSHILPTVPLAQALRALGHEVRYATGGDIRAVAEAGLCAVDVSPGVNYAKLFVPDDTDVTDPMHSEGLGEGFFAEMFARVSAVAVDGALRTARSWRPDLVVHTPTQGAGPLTAAALQLPCVELPLGPADSEPGLGALIRRAMSKDYERHGVTGEPTGSVRLTTTPPSVEALLPEDRRSPGAWPMRYVPYNGGAVLPDWLPPAAGRRRIAVTLGSIDALSGGIAKLAPLFSEVADVDAEFVLTLGGGDLALLGELPANVPVVEWIPLGALLETCDAIIHHGGSGTLLTALAAGVPQCVIPHGSYQDTNRDVLTGLGIGFDAEAGSLGAEQCRRLLDDAGLREAALRVRQEMSEMPPPAETAAKLVALAG	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	89.15	gnl|BL_ORD_ID|1684|hsp_num:0	1824			48	1209	oleandomycin
BGC0000251.1|Nogalamycin_12 # 11057 # 11884 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.756	BGC0000251.1|Nogalamycin_12 	11057	11884	+	Loose	980	28.1054	opcM	29.0	3003037	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACAGTATTGGTAACCGGAGCCACAGGAAACGTCGGCCGGCACGTCGTCACCGGGCTACTGGCCGCCGGCCGCCGGGTGCGGGCGCTGACCCGCACACCCGACCGGTCCGGCCTGCCCGGCGGCGCGGAGATCACAGGCGGCGACCTGACCCGCCCGGAGACCTACGAGCGGATGCTGGACGGTGTCGAAGCCGTCTACCTGTTCCCCGTCCCGGAGACCGCCGCGGCGTTCGCCGGGGCCGCGCGACGGGCCGGTGTCCGGCGGATCGTGGTGCTCTCCTCGGACTCCGTCACCGACGGCACCGACACCGGAGGACACCGGCGCGTGGAACTGGCCGTGGAGGACACGGGGCTCGAGTGGACCCATGTGCGCCCCGGCGAGTTCGCGCTCAACAAGGTCACCCTGTGGGCGCCGTCGATCCGCGCGGAGGGCGTCGTCCGGTCCGCGTATCCGGACGCCCGGGTGGCCCCGGTGCACGAGGCCGACGTCGCGGCCGTCGCGGTGACCGCGCTGCTGAAGGAGGGGCACGCCGGCCGCGCCTACAGCGTGACCGGACCGCAGGCCCTCACCCAGCGCGAACAGGTCCGCGCGGTAGGGGAGGGGCTCGGCCGGTCCCTCGCCTTCGTCGAGGTGACCCCCGGGCAGGCGCGGGCCGACCTGACCGCCCAGGGGCTGCCCGCGCCCATCGCCGACTACGTCCTCGCCTTCCAAGCCGGGTGGACCGAGCGGCCCGCCCCCGCCCGGCCGACCGTGCGGGAGGTCACCGGCCGGCCCGCCCGCACGCTCGCCCAGTGGGCCGCCGACCACCGAGCGGACTTCCGGTGA	MTVLVTGATGNVGRHVVTGLLAAGRRVRALTRTPDRSGLPGGAEITGGDLTRPETYERMLDGVEAVYLFPVPETAAAFAGAARRAGVRRIVVLSSDSVTDGTDTGGHRRVELAVEDTGLEWTHVRPGEFALNKVTLWAPSIRAEGVVRSAYPDARVAPVHEADVAAVAVTALLKEGHAGRAYSVTGPQALTQREQVRAVGEGLGRSLAFVEVTPGQARADLTAQGLPAPIADYVLAFQAGWTERPAPARPTVREVTGRPARTLAQWAADHRADFR	MDNMHNTNGLMRFAKVAAASTLLATLLAACAVGPDYQRPDAVVPAAFKEAPTLAAGEQAGTWKTAEPSDGRTPRRMVKVFGDPVLDSLETQALAANQNLKAAAARVEEARAATRSARSQWFPQVGAGFGPTREGLSSASQFQPQGTGPTNATLWRAQGTVSYEADLFGRVGRNVEASRADQAQSEALFRSVQLALQADVAQNYFELRQLDSDQDLYHRTVELREQALKLVQRRFNEGDISELDVSRAKNELASAQADAVDVARRRAASEHALAILLGKAPADFAFKETPIVPVAVKIPPGLPSALLERRPDVSAAERAMAAANARIGLAKSAYFRSSISPGRSAISVDARQPVPVVEPYFLLGPFAGTALTLPLFDGGRRAAGVQQARAQYDEQGANYRQQVLVAFREVEDNLADLRLLDDQIRAQEAAVNASRRAATLSRSEYQEGEVAYLDVIDSERSVLQSQLQANQLTGAQAVSTVNLIRALGGGWGNAPAPTAVGDAASGKADVAAR	53.71	gnl|BL_ORD_ID|1918|hsp_num:0	2130			1215	1479	
BGC0000251.1|Nogalamycin_14 # 13335 # 13754 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.669	BGC0000251.1|Nogalamycin_14 	13335	13754	-	Loose	450	23.483	cphA2	28.57	3003099	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CphA beta-lactamase	ATGTCAACGACCGCGAACAAGGAACGCTGCCTGGAGATGGTGGCCGCATGGAACCGGTGGGACGTCTCCGGGGTGGTCGCGCACTGGGCACCCGACGTCGTCCACTACGACGACGAGGACAAACCGGTGAGCGCCGAGGAGGTCGTACGGCGTATGAACAGCGCGGTGGAGGCCTTCCCGGACCTTCGTCTGGACGTGCGGAGCATCGTGGGCGAGGGCGACCGCGTGATGCTGCGGATCACCTGCTCGGCCACGCACCAGGGCGTGTTCATGGGCATCGCCCCCACCGGCCGCAAGGTCCGCTGGACCTACTTGGAGGAGCTGCGCTTCTCCGAAGCCGGCAAGGTCGTGGAGCACTGGGACGTCTTCAACTTCTCCCCGCTGTTCCGGGACCTGGGCGTGGTGCCGGACGGACTGTGA	MSTTANKERCLEMVAAWNRWDVSGVVAHWAPDVVHYDDEDKPVSAEEVVRRMNSAVEAFPDLRLDVRSIVGEGDRVMLRITCSATHQGVFMGIAPTGRKVRWTYLEELRFSEAGKVVEHWDVFNFSPLFRDLGVVPDGL	MMKGWMKCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRAFYAGPAHTPDGIFVYFPDQQVLYGNCILKEKLGNLSFADVKAYPRTLERLKAMKLPIKTVVGGHDSPLHGPELIDHYEALIKAAPQS	54.72	gnl|BL_ORD_ID|1310|hsp_num:0	1428			387	513	
BGC0000251.1|Nogalamycin_16 # 14577 # 15377 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.744	BGC0000251.1|Nogalamycin_16 	14577	15377	+	Loose	450	43.1282	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	27.34	3004045	protein variant model	G93A	n/a	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	ATGTCACCCGCCCCCAGCCCCACGCCTTCCCCCGGCCCCGCCCCCGGGAGCGAACCCGCGCCGCTCGCCGTGATCGTCACCGGCGGCGGTTCGGGTATCGGCCGGGCCACCGCCCGCGCCTTCGCCGCTCAGGGTGCGAAGGTGCTCGTCGTCGGCCGTACCGAGGACGCGCTCGCGCAGACCGCCGAGGGCTGTGCGGACATGCGTGTGCTCGTCGCCGACGTGGCCTCGCCCGACGGGCCGCAGGCGGTCGTCAACGCCGCCCTGCGGGAGTTCGGGAGGATCGACGTCCTGGTCAACAACGCTGCCGTGGCGGGCATGGAGACCCTGCAGACCGTCGACCGGGACGCCGTGGCACGGCAGTTCGGCACCAATCTGACGGCTCCCCTCTTCCTCGTCCAGTCCGCACTCGGCGCGCTGGAGAAGTCGCGCGGCATCGTCGTCAACGTGGGGACCGCCGCGACCCTGGGCCTGCGCGCCGCCCCGACCGGCGCGCTGTACGGGGCGAGCAAGGTGGCCCTCGACTACCTGACCCGGACCTGGGCCGTCGAACTGGCCCCCCGGGGCATCCGTGTCGTCGGCGTGGCACCCGGGGTGATCGACACGGGCATCGGCGTCCGCATGGGCATGACCCCGGAGGGCTACCGGGAGTTCCTGACCGGCATGGGCGGCAGGGTGCCCGTGGGCCGGGTCGGCCGTCCGGAGGACGTGGCCTGGTGGATCGTCCAGCTCGCCCGCCCGGAGGCCGGCTACGCGACGGGCATGGTCGTCCCCGTCGACGGCGGGCTGTCGCTGGTCTGA	MSPAPSPTPSPGPAPGSEPAPLAVIVTGGGSGIGRATARAFAAQGAKVLVVGRTEDALAQTAEGCADMRVLVADVASPDGPQAVVNAALREFGRIDVLVNNAAVAGMETLQTVDRDAVARQFGTNLTAPLFLVQSALGALEKSRGIVVNVGTAATLGLRAAPTGALYGASKVALDYLTRTWAVELAPRGIRVVGVAPGVIDTGIGVRMGMTPEGYREFLTGMGGRVPVGRVGRPEDVAWWIVQLARPEAGYATGMVVPVDGGLSLV	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	101.53	gnl|BL_ORD_ID|4712|hsp_num:0	2666			24	759	triclosan
BGC0000251.1|Nogalamycin_17 # 15450 # 16019 # 1 # ID=1_17;partial=01;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.732	BGC0000251.1|Nogalamycin_17 	15450	16019	+	Loose	1650	27.7202	Bacillus subtilis mprF	46.15	3003324	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	GTGCAGGAAACCGAACCCGGCGTCCCCGCGGACCTGCCCGCCGAGAGCGACCCTGCCGCCCTGGAGCGCCTCGCCGCACGGTACCGGCGGGACGGCTACGTCCACGTCCCCGGCGTCCTCGACGCCGGGGAGGTCGCCGAATACCTGGCCGAGGCCCGTCGGCTCCTCGCCCACGAGGAGTCCGTGCGCTGGGGCTCCGGCGCCGGCACCGTCATGGACTACGTCGCCGACGCCCAGCTCGGCAGCGACACGATGCGCCGCCTTGCCACCCACCCGCGCATCGCCGCCCTCGCCGAGTACCTGGCCGGCTCGCCCCTGAGGCTGTTCAAGCTGGAGGTGCTGCTCAAGGAGAACAAGGAGAAGGACGCCTCGGTCCCCACCGCCCCGCACCACGATGCGTTCGCCTTCCCGTTCTCCACCGCCGGCACCGCCCTGACGGCGTGGGTCGCGCTGGTCGACGTCCCGGTGGAACGCGGCTGCATGACCTTCGTCCCCGGATCACACCTGCTGCCGGATCCCGATACCGGCGACGAGCCGTGGGCCGGGGCCTTCACCCGGCCGGGAGAGATC	MQETEPGVPADLPAESDPAALERLAARYRRDGYVHVPGVLDAGEVAEYLAEARRLLAHEESVRWGSGAGTVMDYVADAQLGSDTMRRLATHPRIAALAEYLAGSPLRLFKLEVLLKENKEKDASVPTAPHHDAFAFPFSTAGTALTAWVALVDVPVERGCMTFVPGSHLLPDPDTGDEPWAGAFTRPGEI	MLIKKNALSILKIVFPIAVLLFVIYQSKKELTNLSFKRTLMVINGLERTDLFMLVLIGLLAVAAMSLYDYVLKYSLRLSITNGKVFRVSWIANSFNNVLGFGGLAGVGLRMMFYKEHTKDHKALVKGIAWLTSSMLLGLSVFSIFVAARVLPVDEVIHEKPWLWAVVIGFALILPLSLAVSKIKDRKAGDEENADKVKNPIFAYIGASVVEWLMAGTVIYFALFAMGIHADIRYVFGVFVIAAIGGMISLVPGGFGSFDLLFLLGMEQLGYHQEAIVTSIVLYRLAYSFIPFILGLFFAAGDLTENTMKRLETNPRIAPAIETTNVLLVVQRAVLVRILQGSLSLIVFVAGLIVLASVSLPIDRLTVIPHIPRPALLLFNGLSLSSALILLILPIELYKRTKRSYTMAITALVGGFVFSFLKGLNISAIFVLPMIIVLLVLLKKQFVREQASYTLGQLIFAVALFTVALFNYNLIAGFIWDRMKKVLRHEYFVHSTSHITHATIMAIIIVPLFFLIFTVVYHKRTKPIGEKADPERLAAFLNEKGGNALSHLGFLGDKRFYFSSDGNALLLFGKIARRLVVLGDPSGQRESFPLVLEEFLNEAHQKGFSVLFYQIEREDMALYHDFGYNFFKLGEEAYVDLNTFTLTGKKKAGLRAINNRFEREEYTFHVDHPPFSDAFLEELKQISDEWLGSKKEKGFSLGFFDPSYLQKAPIAYMKNAEGEIVAFANVMPMYQEGEISVDLMRYRGDAPNGIMDALFIRMFLWAKEEGCTSFNMGMAPLANVGTAFTSFWSERFAAVIFNNVRYMYSFSGLRAFKEKYKPEWRGKYLAYRKNRSLSVTMFLVTRLIGKSKKDSV	22.20	gnl|BL_ORD_ID|1987|hsp_num:0	1558			888	966	defensin
